StartUp Slam on BIO-Europe 2017

Out of multiple applications MT-Medicals (a subsidiary of Target Medicals for anti-TB drug project) became a contestant of StartUp Slam, organised by Johnson & Johnson and EBD Group.

Only eight companies were selected to present in front of panel of judges, consisted of leading experts from industry.

https://labiotech.eu/startup-slam-bio-europe-2017-winner-jnj-innovation/

https://www.youtube.com/watch?time_continue=39&v=ULyr5qc3ejM 

http://www.ebdgroup.com/corp/amylon-therapeutics-targeting-central-nervous-system-disorders-wins-startup-slam-competition-at-bio-europe-berlin/